Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Phone513-762-6690
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.67 billion
Profitability
Miscellaneous
Employees14,813
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed declared a quarterly dividend on Friday, November 2nd. Investors of record on Monday, November 12th will be paid a dividend of $0.30 per share on Monday, December 3rd. This represents a $1.20 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Thursday, November 8th. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed announced that its board has approved a share repurchase plan on Wednesday, March 7th 2018, which authorizes the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) issued its earnings results on Monday, October, 29th. The company reported $3.07 earnings per share for the quarter, beating analysts' consensus estimates of $2.80 by $0.27. The company earned $444.15 million during the quarter, compared to analysts' expectations of $445.16 million. Chemed had a net margin of 11.73% and a return on equity of 35.13%. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $2.15 earnings per share. View Chemed's Earnings History.
When is Chemed's next earnings date?
How can I listen to Chemed's earnings call?
Chemed will be holding an earnings conference call on Thursday, February 21st at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8447432500.
What price target have analysts set for CHE?
2 brokerages have issued 12-month price objectives for Chemed's shares. Their predictions range from $321.00 to $390.00. On average, they anticipate Chemed's share price to reach $355.50 in the next year. This suggests a possible upside of 12.9% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
Press coverage about CHE stock has trended neutral this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a news impact score of 0.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the next several days.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
- Mr. David P. Williams, Exec. VP & CFO (Age 58)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
- Mr. Spencer S. Lee, Exec. VP (Age 63)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 40)
Who are Chemed's major shareholders?
Chemed's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.41%), Acadian Asset Management LLC (3.60%), Fisher Asset Management LLC (2.98%), Riverbridge Partners LLC (2.93%), Investec Asset Management LTD (1.58%) and Bank of New York Mellon Corp (1.51%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which institutional investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, D. E. Shaw & Co. Inc., Two Sigma Investments LP, Dimensional Fund Advisors LP, California Public Employees Retirement System, Gamco Investors INC. ET AL, Riverbridge Partners LLC and Squarepoint Ops LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which institutional investors are buying Chemed stock?
CHE stock was bought by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Bank of America Corp DE, Bank of Montreal Can, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Barclays PLC, Eaton Vance Management, Investec Asset Management LTD and Copeland Capital Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $314.92.
How big of a company is Chemed?
Chemed has a market capitalization of $5.04 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
